SG91892G - Sdk peptides - Google Patents

Sdk peptides

Info

Publication number
SG91892G
SG91892G SG918/92A SG91892A SG91892G SG 91892 G SG91892 G SG 91892G SG 918/92 A SG918/92 A SG 918/92A SG 91892 A SG91892 A SG 91892A SG 91892 G SG91892 G SG 91892G
Authority
SG
Singapore
Prior art keywords
sdk
peptides
sdk peptides
Prior art date
Application number
SG918/92A
Other languages
English (en)
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of SG91892G publication Critical patent/SG91892G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SG918/92A 1989-03-11 1992-09-11 Sdk peptides SG91892G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898905606A GB8905606D0 (en) 1989-03-11 1989-03-11 Peptides

Publications (1)

Publication Number Publication Date
SG91892G true SG91892G (en) 1992-12-04

Family

ID=10653152

Family Applications (1)

Application Number Title Priority Date Filing Date
SG918/92A SG91892G (en) 1989-03-11 1992-09-11 Sdk peptides

Country Status (32)

Country Link
US (1) US5112811A (es)
JP (1) JPH0347197A (es)
KR (1) KR0133850B1 (es)
AR (1) AR245139A1 (es)
AT (1) AT402822B (es)
AU (1) AU631197B2 (es)
BE (1) BE1003996A3 (es)
CA (1) CA2011874C (es)
CH (1) CH680666A5 (es)
DE (1) DE4007605B4 (es)
DK (1) DK173932B1 (es)
ES (1) ES2023746A6 (es)
FI (1) FI901196A0 (es)
FR (2) FR2644164A1 (es)
GB (2) GB8905606D0 (es)
GR (1) GR1000344B (es)
HK (1) HK95392A (es)
IE (1) IE64762B1 (es)
IN (1) IN173870B (es)
IT (1) IT1240933B (es)
LU (1) LU87696A1 (es)
MA (1) MA21770A1 (es)
MY (1) MY106274A (es)
NL (1) NL194918C (es)
NO (1) NO901129L (es)
NZ (1) NZ232815A (es)
OA (1) OA09197A (es)
PT (1) PT93380B (es)
SE (1) SE9000793L (es)
SG (1) SG91892G (es)
TN (1) TNSN90027A1 (es)
ZA (1) ZA901718B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK31991D0 (da) * 1991-02-25 1991-02-25 Carlbiotech Ltd As Peptid og farmaceutisk praeparat indeholdende et saadant peptid
GB9211668D0 (en) * 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
DE4224509C2 (de) * 1992-07-24 1995-04-20 Ruhenstroth Bauer Gerhard Prof Wirkstoff zur Hemmung der Proliferationsrate von Leberzellen
RU2302870C1 (ru) * 2006-06-22 2007-07-20 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Средство, обладающее геропротекторной активностью, и способ его получения

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US216088A (en) * 1879-06-03 Improvement in bale-ties
DE2602443A1 (de) * 1975-04-04 1976-10-21 Univ California Biologisch aktive polypeptide
US4816449A (en) * 1984-08-09 1989-03-28 Immunetech Pharmaceuticals Immunotherapeutic anti-inflammatory peptide agents
FR2565985B1 (fr) * 1984-06-19 1987-09-25 Rhone Poulenc Sante Nouvelles substances biologiquement actives obtenues a partir de la caseine bovine, leur procede de preparation et les compositions qui les contiennent
EP0200748B1 (en) * 1984-10-15 1991-02-06 Cetus Corporation Human tumor necrosis factor
FR2601678B1 (fr) * 1986-07-18 1989-11-24 Inst Nat Sante Rech Med Peptides comprenant la sequence seryl-aspartyl-lysyl-prolyle, procede pour l'extraction du tetrapeptide correspondant, et applications, notamment a la protection de la moelle osseuse au cours de traitements anticancereux par la chimiotherapie
FR2622587B1 (fr) * 1987-10-30 1990-12-21 Inst Vaisseaux Sang Peptide lysyl-arginyl-aspartyl-serine et ses applications en tant que medicament, notamment antithrombotique
JPH0742313B2 (ja) * 1988-03-28 1995-05-10 日立化成工業株式会社 新規ペプチド、その塩及びペプチド性抗アレルギー剤

Also Published As

Publication number Publication date
ES2023746A6 (es) 1992-02-01
DE4007605A1 (de) 1990-09-13
MY106274A (en) 1995-04-29
JPH0347197A (ja) 1991-02-28
ATA53290A (de) 1997-01-15
GB8905606D0 (en) 1989-04-26
OA09197A (fr) 1992-06-30
MA21770A1 (fr) 1990-10-01
GB2228937B (en) 1992-07-08
IN173870B (es) 1994-07-30
NO901129L (no) 1990-09-12
NO901129D0 (no) 1990-03-09
KR0133850B1 (ko) 1998-04-21
FR2644065A1 (fr) 1990-09-14
GB9005069D0 (en) 1990-05-02
IT1240933B (it) 1993-12-27
BE1003996A3 (fr) 1992-09-08
HK95392A (en) 1992-12-04
GR900100164A (en) 1990-07-31
SE9000793D0 (sv) 1990-03-06
CA2011874A1 (en) 1990-09-11
DK62690D0 (da) 1990-03-09
NL9000551A (nl) 1990-10-01
DK62690A (da) 1990-09-12
FR2644164B1 (es) 1995-03-17
IT9019630A1 (it) 1991-09-09
IT9019630A0 (it) 1990-03-09
CH680666A5 (en) 1992-10-15
AR245139A1 (es) 1993-12-30
GB2228937A (en) 1990-09-12
ZA901718B (en) 1990-12-28
US5112811A (en) 1992-05-12
AU631197B2 (en) 1992-11-19
AT402822B (de) 1997-09-25
DE4007605B4 (de) 2006-03-23
SE9000793L (sv) 1990-09-12
IE64762B1 (en) 1995-09-06
PT93380A (pt) 1990-11-07
KR900014426A (ko) 1990-10-23
NL194918B (nl) 2003-03-03
LU87696A1 (fr) 1990-07-24
PT93380B (pt) 1997-01-31
TNSN90027A1 (fr) 1991-03-05
FR2644164A1 (fr) 1990-09-14
GR1000344B (el) 1992-06-25
CA2011874C (en) 1998-07-21
AU5117590A (en) 1990-09-13
DK173932B1 (da) 2002-02-25
FI901196A0 (fi) 1990-03-09
IE900850L (en) 1990-09-11
NZ232815A (en) 1992-06-25
FR2644065B1 (fr) 1994-10-07
NL194918C (nl) 2003-07-04

Similar Documents

Publication Publication Date Title
ZA901737B (en) Peptides
EP0504168A4 (en) Synthetic calcitonin peptides
EP0448099A3 (en) Novel peptides
GB8920357D0 (en) Peptides
GB8807427D0 (en) Peptides
GB9016810D0 (en) Peptides
GB8821077D0 (en) Peptides
GB2228937B (en) Sdk peptides
GB9204274D0 (en) Novel peptides
GB8828097D0 (en) Peptides
GB8828098D0 (en) Peptides
GB8914943D0 (en) Peptides
IE892815L (en) Peptides
GB8914942D0 (en) Peptides
ZA909232B (en) Peptides
GB8911105D0 (en) Peptides
IE892338L (en) Peptides
IE893820L (en) Peptides
IE890703L (en) Peptides
ZA906063B (en) Psycho-pharmacological peptides
IE893821L (en) Peptides
GB8914944D0 (en) Peptides
IE893022L (en) Peptides
IE891133L (en) Peptides
IE891330L (en) Peptides